Lindbrook Capital’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-520
| Closed | -$2.43K | – | 2851 |
|
|
2024
Q2 | $2.43K | Buy |
+520
| New | +$2.43K | ﹤0.01% | 2285 |
|
|
2024
Q1 | – | Sell |
-227
| Closed | -$2.3K | – | 2676 |
|
|
2023
Q4 | $2.3K | Buy |
227
+89
| +64% | +$902 | ﹤0.01% | 2213 |
|
|
2023
Q3 | $1.08K | Sell |
138
-2
| -1% | -$16 | ﹤0.01% | 2334 |
|
|
2023
Q2 | $1.15K | Sell |
140
-35
| -20% | -$288 | ﹤0.01% | 2341 |
|
|
2023
Q1 | $1.27K | Sell |
175
-71
| -29% | -$515 | ﹤0.01% | 2404 |
|
|
2022
Q4 | $2.18K | Buy |
+246
| New | +$2.18K | ﹤0.01% | 2194 |
|
|
2022
Q3 | – | Sell |
-30
| Closed | – | – | 2700 |
|
|
2022
Q2 | $0 | Sell |
30
-108
| -78% | – | ﹤0.01% | 2562 |
|
|
2022
Q1 | $3K | Sell |
138
-329
| -70% | -$7.15K | ﹤0.01% | 1808 |
|
|
2021
Q4 | $12K | Buy |
467
+437
| +1,457% | +$11.2K | ﹤0.01% | 1197 |
|
|
2021
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 1699 |
|
|
2021
Q2 | $2K | Hold |
30
| – | – | ﹤0.01% | 1574 |
|
|
2021
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 1694 |
|
|
2020
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 1435 |
|
|
2020
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 1535 |
|
|
2020
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 1541 |
|
|
2020
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 1434 |
|
|
2019
Q4 | $1K | Sell |
30
-90
| -75% | -$3K | ﹤0.01% | 1372 |
|
|
2019
Q3 | $3K | Hold |
120
| – | – | ﹤0.01% | 1163 |
|
|
2019
Q2 | $2K | Hold |
120
| – | – | ﹤0.01% | 1217 |
|
|
2019
Q1 | $2K | Hold |
120
| – | – | ﹤0.01% | 1215 |
|
|
2018
Q4 | $2K | Buy |
+120
| New | +$2K | ﹤0.01% | 1161 |
|